Alvogen has secured a low-risk shot at the treatment-resistant suicidal bipolar depression market. The deal gives the drugmaker the U.S. license to NRx Pharmaceuticals’ NRX-101—and it will only make ...
ARLINGTON, VA and REYKJAVIK, ICELAND--(Marketwired - Apr 21, 2017) - Global pharmaceutical company Alvogen will market the Kerecis fish-skin-based diabetic wound treatment products in Asia starting in ...
March 7 (Reuters) - New Jersey-based pharmaceuticals firm Alvogen is to buy County Line Pharmaceuticals, another U.S. maker of generic drugs, for approximately $300 million, according to people ...
Summit-based Celgene Corp., Lotus Pharmaceutical Co., and Alvogen, headquartered in Pine Brook, (collectively, Alvogen) announced on Friday the settlement of their litigation relating to patents for ...
Significant step towards Alvogen's ambition to be a top-5 business in Asia Pacific Region (APAC) Third significant acquisition in region since 2012, highlighting Alvogen's role as leading regional ...
Credit: Alvogen, Inc. Fentanyl is an opioid agonist indicated for the management of severe or persistent pain in opioid-tolerant patients. At this time, Alvogen Inc has received 1 serious adverse ...
Alvogen, a Pine Brook-based pharmaceutical company, announced Tuesday that it has agreed to acquire Omega Bittner, a Russia-based pharmaceutical firm owned by Perrigo Company plc.Alvogen, a Pine Brook ...
Iceland-based Alvogen has a business model that leans heavily on contract manufacturers to get better prices and faster delivery of the products it manufactures. One of those has had manufacturing ...
LONDON (Reuters) - European private equity fund CVC and Singaporean sovereign wealth fund Temasek [TEM.UL] are to buy a controlling stake in the pharmaceutical firm Alvogen, its chairman and chief ...
Alvogen employees pose before starting this year’s clean up. (Photo by Tyler Murphy) NORWICH – Every September, the employees of Alvogen take part in a community clean-up project. This year it was on ...
Case Name: Pharmacyclics LLC v. Alvogen Pine Brook LLC, No. 19-0434, 2021 WL 3680317 (D. Del. Aug. 19, 2021) (Connolly, J.) Drug Product and Patent(s)-in-Suit ...
PINEBROOK, N.J.--(BUSINESS WIRE)--Alvogen, the international pharmaceuticals company announced today that it has acquired Dream Pharma (“Dream”) in South Korea for US$ 187 million in cash. Dream will ...